Skip to content

Total Revenue at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$11.49B+2.6%
Merck & Co. logo
Merck & Co.MRK
$16.29B+4.9%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$3.61B+19.0%
AbbVie logo
AbbVieABBV
$15B+12.4%
Immunome logo
ImmunomeIMNM
$0-100%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$6.56M

Segments

By segment

See full
Reportable segment$17M-39.3%

By product

See full
R&D services$2M0.0%

Other financials

Income statement

See full
Operating income-$134.0M-9.8%
Net income-$128.0M-14.3%
EPS (diluted)-$1.02+10.5%

Balance sheet

See full
Cash & equivalents$201.0M+4.7%
Total debt$113.0M+88.3%
Total equity$524.0M-1.3%
Total assets$997.0M-13.8%

Cash flow

See full
Operating cash flow-$138.0M-4.5%
CapEx--100%
Free cash flow-$138.0M-3.8%

Valuation

See full
Market cap$3.8B+317%
Enterprise value$3.72B+376%
P/S16.1×+9.6×

Profitability

See full
Operating margin-168.6%-52.7pp
Net margin-156.4%-47.5pp
FCF margin-207.2%

Returns & leverage

See full
Return on equity-70%+8.4pp
Debt / equity0.2×+0.1×
Current ratio-1.3×

Where this comes from

Reported directly by Arcus Biosciences in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcus Biosciences's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arcus Biosciences's total revenue?
Arcus Biosciences (RCUS) reported total revenue of $17M in Q1 2026.
How has Arcus Biosciences's total revenue changed year-over-year?
Arcus Biosciences's total revenue decreased by 39.3% year-over-year, from $28M to $17M.
What is the long-term trend for Arcus Biosciences's total revenue?
Over 4 years (2021 to 2025), Arcus Biosciences's total revenue has grown at a -10.4% compound annual growth rate (CAGR), from $383M to $247M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.